AbbVie (ABBV) Financials
AbbVie (ABBV) Historical Financial Statements and Key Metrics for 2011 - 2023
Full AbbVie financials for 2011 - 2023 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
AbbVie Income Statements
(in $ 000,000's)
Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
2023-Dec-31 | 14,301 | 11,915 (83.3 %) | 4,499 (31.5 %) | 822 (5.7 %) | 4,183 | 0.46 |
2023-Sep-30 | 13,927 | 7,442 (53.4 %) | 2,281 (16.4 %) | 1,778 (12.8 %) | 2,442 | 1.00 |
2023-Jun-30 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
2023-Mar-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
2022-Dec-31 | 15,121 | 10,951 (72.4 %) | 5,745 (38.0 %) | 2,473 (16.4 %) | 4,647 | 1.38 |
2022-Sep-30 | 14,812 | 9,790 (66.1 %) | 4,603 (31.1 %) | 3,949 (26.7 %) | 7,162 | 2.21 |
2022-Jun-30 | 14,583 | 10,413 (71.4 %) | 3,295 (22.6 %) | 924 (6.3 %) | 3,787 | 0.51 |
Full historical income statements for 2011 - 2023 is included in the
US Historical Financials dataset.
AbbVie Balance Sheets
(in $ 000,000's)
Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
2023-Dec-31 | 134,711 | 124,314 | 59,385 | 10,360 | 12,816 |
2023-Sep-30 | 136,221 | 124,092 | 60,746 | 12,094 | 13,290 |
2023-Jun-30 | 135,367 | 122,469 | 61,015 | 12,866 | 8,766 |
2023-Mar-31 | 134,544 | 121,241 | 62,093 | 13,274 | 6,722 |
2022-Dec-31 | 138,805 | 121,518 | 63,271 | 17,254 | 9,229 |
2022-Sep-30 | 141,325 | 125,298 | 69,606 | 15,994 | 11,879 |
2022-Jun-30 | 143,186 | 128,498 | 72,932 | 14,653 | 9,961 |
Full historical balance sheet data for 2011 - 2023 is included in the
US Historical Financials dataset.
AbbVie Cash Flow Statements
(in $ 000,000's)
Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
2023-Dec-31 | 4,753 | -800 | -4,449 | 4,548 |
2023-Sep-30 | 7,574 | -369 | -2,661 | 7,355 |
2023-Jun-30 | 6,319 | -341 | -3,920 | 6,141 |
2023-Mar-31 | 4,193 | -499 | -6,192 | 4,018 |
2022-Dec-31 | 7,428 | -448 | -9,634 | 7,215 |
2022-Sep-30 | 7,602 | 1,286 | -5,518 | 7,425 |
2022-Jun-30 | 5,005 | 130 | -2,679 | 4,862 |
Full historical cash flow data for 2011 - 2023 is included in the
US Historical Financials dataset.
AbbVie Key Valuation and Operating Metrics
Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
2023-Dec-31 | 273,668 | 320,239 | 19.14 | 83.23 | 26.42 |
2023-Sep-30 | 263,098 | 310,557 | 18.89 | 36.99 | 21.75 |
2023-Jun-30 | 238,068 | 290,324 | 17.17 | 29.41 | 18.50 |
2023-Mar-31 | 0 | 0 | 0.00 | 0.00 | 0.00 |
2022-Dec-31 | 285,804 | 339,874 | 18.90 | 28.89 | 16.56 |
2022-Sep-30 | 237,686 | 295,460 | 16.05 | 15.05 | 14.86 |
2022-Jun-30 | 271,093 | 335,504 | 18.59 | 73.35 | 18.50 |
Full historical valuation and operating metrics for 2011 - 2023 are included in the
US Historical Financials dataset.